LCM
TTPH

Laurion Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Laurion Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,535
Closed -$229K – 1128
2015
Q3 		$229K Buy
+1,535
New +$1.13M ﹤0.01% 656

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Laurion Capital Management's TTPH Position: Q4 2015 in Review

Laurion Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 1,535 shares — an estimated $229K sold.

Laurion Capital Management first reported a position in TTPH in Q3 2015 and held it in 1 quarter. The position peaked at $229K in Q3 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Laurion Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Laurion Capital Management sold 1,535 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $229K.
  • Laurion Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Laurion Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $229K in Q3 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Laurion Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.